Vcanbio Cell & Gene Engineering Corp., Ltd
Status: Publicly traded
Direct answer
Vcanbio Cell & Gene Engineering Corp., Ltd is publicly traded on SHH under the ticker 600645.SS.
Vcanbio Cell & Gene Engineering Corp., Ltd, established in 1992 and headquartered in Tianjin, China, primarily focuses on providing cell preparation and cryopreservation services across the People's Republic of China. The company's offerings include the handling and storage of a diverse array of stem cells, such as hematopoietic stem cells derived from umbilical cord blood, umbilical cord mesenchymal stem cells,...
Can you invest in Vcanbio Cell & Gene Engineering Corp., Ltd?
Yes. Vcanbio Cell & Gene Engineering Corp., Ltd trades publicly on SHH as 600645.SS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Vcanbio Cell & Gene Engineering Corp., Ltd
Detailed equity research is provided by MarketSnap.